ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1927

Development of the PREVAIL model of care: Optimizing feasibility and acceptability for trial implementation

Louise Thoma1, Joel Thompson2, Jason Sharpe3, Beth Jonas4, Patti Katz5 and Kelli Allen6, 1University of North Carolina, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Cary, NC, 3Flatiron Health, Durham, NC, 4University of North Carolina at Chapel Hill, Chapel Hill, NC, 5UCSF, San Rafael, CA, 6University of North Carolina, Durham, NC

Meeting: ACR Convergence 2025

Keywords: Access to care, Occupational therapy, physical function, physical therapy, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1914–1935) Health Services Research Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Exercise guidance and referral to physical therapy are not consistently delivered when appropriate in rheumatology care for adults with rheumatoid arthritis (RA). The PREVAIL model of care uses a screening survey assessing disability and functional impairment at a routine rheumatology visit to guide the delivery of exercise guidance and rehabilitation referrals for adults with RA who need it (Figure 1). The purpose of this study was to determine the feasibility and acceptability of the PREVAIL model of care and inform modifications to the model of care for feasibility testing in a pilot clinical trial.

Methods: We used a multi-method approach to learn about the feasibility and accessibility of the PREVAIL model of care from the perspectives of patients, rheumatology clinicians, and physical therapists. We invited adults with RA who received rheumatology care at an academic rheumatology clinic to complete a survey to test the feasibility of the proposed screening tool. We then selected participants across a spectrum of functional limitations to participate in semi-structured interviews via video or phone call. We also interviewed clinicians. A rapid qualitative approach was used to analyze patient and clinician perspectives on feasibility and acceptability. Using the results, we refined the PREVAIL model of care in preparation for a pilot clinical trial.

Results: Of 1508 potential participants, 309 completed the disability screening tool in the survey, which categorized the respondents as no disability (29/309, 9.4%), at risk for disability (30/309, 9.7%), and current disability (250/309, 80.9%). We conducted 30 interviews (24 adults with RA, 5 rheumatologists, 1 nurse practitioner, 6 physical therapists). Patients, rheumatology clinicians, and physical therapists generally perceived the PREVAIL model of care to be a feasible and acceptable approach to systematically integrating exercise guidance and rehabilitation into routine care for RA.  Four major themes emerged regarding feasibility and acceptability: (1) The PREVAIL Model of Care is acceptable and adds value; (2) Knowledge gaps regarding the value and role of physical therapy may hinder PREVAIL Model of Care implementation; (3) PREVAIL Model of Care may facilitate communication; and (4) Modifications will improve PREVAIL Model of Care feasibility. Insights from these themes led to modifications to optimize pilot testing for the PREVAIL model of care (Table, Figure 2).

Conclusion: The PREVAIL model of care was perceived as a feasible and acceptable approach to addressing the current barriers to exercise guidance and rehabilitation referral in routine RA care.

Supporting image 1Initial PREVAIL Model of Care proposal prior to the study. Abbreviations: S-VLA, Short Valued Life Activities questionnaire; PT, physical therapy

Supporting image 2Themes and major findings supporting feasibility, acceptability, and modifications of the PREVAIL Model of Care

Supporting image 3Refined PREVAIL Model of Care, modified using results of the survey and interview studies. Abbreviations: PT, physical therapy


Disclosures: L. Thoma: None; J. Thompson: None; J. Sharpe: Flatiron Health, 3; B. Jonas: None; P. Katz: None; K. Allen: None.

To cite this abstract in AMA style:

Thoma L, Thompson J, Sharpe J, Jonas B, Katz P, Allen K. Development of the PREVAIL model of care: Optimizing feasibility and acceptability for trial implementation [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/development-of-the-prevail-model-of-care-optimizing-feasibility-and-acceptability-for-trial-implementation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-the-prevail-model-of-care-optimizing-feasibility-and-acceptability-for-trial-implementation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology